In Vivo Evaluation Using Gamma Scintigraphy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In Vivo Evaluation Using Gamma Scintigraphy
The authors discuss gamma scintigraphy as a technique for in vivo evaluation of drugs and delivery systems.


Pharmaceutical Technology


References

1. S. Jain, P. Dani, and R.K. Sharma, Crit. Rev. Ther. Drug 26 (4), 373–426 (2009).

2. S.P. Newman, P.H. Hirst, and I.R. Wilding, Eur. J. Pharm. Sci. 18 (1), 19–22 (2003).

3. Y.S.R. Krishnaina, S. Satyanarayana, and Y.V. Rama Prasad, J. Pharm. Sci. 5 (1), 24–28 (2002).

4. C.G. Wilson and N. Washington, "Gamma Scinitigraphy in the Analysis of the Behavior of Controlled Release Systems," in Handbook of Pharmaceutical Controlled Release Technology (Marcel Dekker, New York, 1st ed., 2005), pp. 551–565.

5. N.K. Jain, "Colon-Specific Drug Delivery Systems," in Advances in Controlled and Novel Drug Delivery (CBS Publishers, New Delhi, India, 1st ed., 2006), pp. 104–109.

6. I.R. Wilding, A.J. Coupe, and S.S. Davis, Adv. Drug. Deliver. Rev. 46 (1), 103–124 (2001).

7. "H.F. Solomn, H.D. Burns, and R.E. Gibson, Drug. Dev. Ind. Pharm. 16 (18), 2655–2673 (1990).

8. G. Meseguer, R. Gurny, and P. Buri, J. Drug Target. 2 (4), 269–288 (1994).

9. A.W. Basit et al., Eur. J. Pharm. Sci. 21 (2–23), 179–189 (2004).

10. "Methods of Radiolabeling," Quotient Bioresearch (Cambridgeshire, UK), http://www.quotientbioresearch.com/methods-radiolabeling/, accessed Oct. 18, 2010.

12. G.A. Digenis, E.P. Sandefer, R.C. Page, and W.J. Doll, Pharm. Sci. Technol. Today, 1 (3), 100–107 (1998).

13. L. Yang, J.S. Chu, and J.A. Fix, "Int. J. Pharm. 235 (1–2), 1–15 (2002).

14. S. Connolly, CRS Newlsetter 25 (4), 16–17 (2008).

15. M.S. Berridges, D.L. Heald, and Z. Lee, Drug. Dev. Res. 59 (2), 208–209 (2003).

16. K. Jones, "New Technology Combo Drives Once-Daily Drug Formulation," http://www.iptonline.com/articles/public/IPT_26_p66nonprint.pdf, accessed Sept. 27, 2010.

17. A.K. Singh, N. Bhardwaj, and A. Bhatnagar, Indian J. Pharm. Sci. 66 (1), 18–25 (2004).

18. "Pharmacoscintigraphy," Quotient Bioresearch (Cambridgeshire, UK), http://www.quotientbioresearch.com/pharmacoscintigraphy, accessed Oct. 18, 2010.

19. P.P. Hazari, et al., Bioconjugate. Chem. 21 (2), 229–239 (2010).

20. A. Pathak et al., ACS. Nano. 3 (6), 1493–1505 (2009).

21. D. Wang et al., Mol. Pharm. 3 (6), 717–725 (2006).

22. IAEA, "Radiation Protection Procedures," in International Atomic Energy Agency Safety Series (New York, 1978).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here